Carfilzomib injection is used alone to treat relapsed (cancer that has come back) or refractory (cancer that didn’t respond to treatment) multiple myeloma (a type of bone marrow cancer) in patients who have received one or more preceding treatments.

Carfilzomib injection is also used together with other medicines (for example, dexamethasone, daratumumab and dexamethasone, lenalidomide and dexamethasone, daratumumab and hyaluronidase-fihj and dexamethasone, and isatuximab and dexamethasone) to treat relapsed or refractory multiple myeloma in patients who have received one to three previous treatments.

Carfilzomib is an antineoplastic agent (cancer medicine). It intermeddles with the growth of cancer cells, which are ultimately destroyed by the body.

The medicine is to be administered only by or under the supervision of your doctor.

The product is available in the following dosing forms:

1. Powder for Solution